Lidocaine Infiltration to See If It Helps Inflammation and Brain Function After Head and Neck Cancer Surgery
Official title: Lidocaine and Neuroimmunomodulation: The Effect of Local Anesthetic Concentration in Head and Neck Cancer Resections
Run by University Medical Centre Ljubljana · NCT07922759 · Data updated 2026-11-12
This study tests whether different amounts of lidocaine injected into the surgical area can influence inflammation and brain-related outcomes after major head and neck cancer surgery in adults.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University Medical Centre Ljubljana Academic / other |
| Locations | 1 site (Ljubljana) |
| Status | Recruiting |
| Started | June 20, 2026 |
| Main results expected | June 2028 |
| Study ends | December 2028 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07922759 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older undergoing oncological head and neck resection with microvascular free-flap reconstruction at the University Medical Centre Ljubljana.
✕Probably not a fit
Patients with certain comorbidities or baseline conditions may not experience measurable cognitive or inflammatory benefits from lidocaine infiltration.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized pilot trial in adults undergoing oncological head and neck resection with microvascular free-flap reconstruction. Participants are assigned to receive either 150 mg or 300 mg of lidocaine infiltrated in the surgical field at the start of surgery, to explore effects on perioperative inflammation, neuronal/glial injury biomarkers, and postoperative cognitive function. The study uses a prospective design to compare dose-related biological and neurocognitive responses in a single-center setting at University Medical Centre Ljubljana. Outcomes will inform whether local lidocaine infiltration at different doses modulates systemic stress and neuroinflammatory processes after major head and neck cancer procedures. No results are provided yet as this is an initial pilot to assess feasibility and signal of effect.
Why it matters
Potential benefit: If successful, the approach could reduce postoperative inflammation and protect brain function after complex head and neck cancer surgery.
How similar studies have gone: Prior perioperative lidocaine studies often focus on intravenous administration; evidence for local infiltration dose effects on neuroinflammation and cognition is limited but exploratory data exist.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients aged 18 years or older. * Patients scheduled for oncological resection of head and neck cancer followed by microvascular soft-tissue free-flap reconstruction. * Body mass index (BMI) \< 30 kg/m². * No known hypersensitivity to amide-type local anesthetics or components of the infiltration solutions. * Ability and willingness to provide written informed consent for participation in the study. Exclusion Criteria: * Refusal to participate or inability to provide written informed consent. * Known hypersensitivity to lidocaine or any component of the infiltration solution. * Heart failure with a left ventricular ejection fraction \< 50%. * Cardiac conduction disorders without an implanted pacemaker. * Uncontrolled epilepsy. * Hepatic or renal insufficiency. * Pregnancy or breastfeeding. * Pre-existing neurological diseases. * Psychiatric disorders. * Preoperative Mini-Mental State Examination (MMSE) score \< 23 points.
Where it's running
-
University Medical Centre Ljubljana
Ljubljana, Slovenia Recruiting
Study contacts
- Principal investigator: Liljana Markova, MD, PhD — University Medical Centre Ljubljana
- Study coordinator: Liljana Markova, MD, PhD
- Email: liljana.markova@kclj.si
- Phone: +38640802662
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Online perioperative education to support head and neck cancer patients and their caregivers
This trial tests a digital education program called CareOrbit to see if it improves understanding, satisfaction, and outcomes for adults with head and neck cancer undergoing reconstructive surgery or laryngectomy.
-
Swallowing Rehab Program for Head and Neck Cancer Patients on Chemoradiation
A structured swallowing rehabilitation program is tested to see if it improves swallowing, jaw mobility, and pain for head and neck cancer patients undergoing chemoradiation.
-
Tests whether far infrared therapy and nerve stimulation help with side effects in head and neck cancer patients receiving chemoradiotherapy
This trial tests if adding far infrared therapy and transcutaneous electrical nerve stimulation to standard care can reduce treatment-related side effects for adults with head and neck cancer undergoing chemoradiotherapy.
-
Oral, Fecal and Tumor Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy
This study tests how the oral, gut, and tumor microbiomes relate to response to first-line immunotherapy in Colombian adults with advanced solid cancers.
-
ICG Fluorescence Imaging to Guide Head and Neck Free Flap Surgery
This trial tests whether using intraoperative indocyanine green (ICG) fluorescence imaging helps surgeons improve flap outcomes compared with standard assessments in adults undergoing head and neck free flap reconstruction.
-
Assessing safety and efficacy of new treatments for advanced solid tumors
This study is testing two new treatments for patients with advanced solid tumors to see if they are safe and effective.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.